Literature DB >> 23123373

Laparoscopic pyeloplasty for ureteropelvic junction obstruction in infants.

Robert M Turner1, Janelle A Fox, Jeffrey J Tomaszewski, Francis X Schneck, Steven G Docimo, Michael C Ost.   

Abstract

PURPOSE: Laparoscopic pyeloplasty and open pyeloplasty have comparable efficacy for ureteropelvic junction obstruction in pediatric patients. The role of laparoscopic pyeloplasty in infants is less well defined. We present our updated experience with laparoscopic pyeloplasty in children younger than 1 year.
MATERIALS AND METHODS: We retrospectively reviewed the records of all 29 infants treated with transperitoneal laparoscopic pyeloplasty for symptomatic and/or radiographic ureteropelvic junction obstruction from May 2005 to February 2012. Patients were followed with renal ultrasound at regular intervals. Treatment failure was defined as the inability to complete the intended procedure, persistent radiographic evidence of obstruction and/or the need for definitive adjunctive procedures.
RESULTS: Transperitoneal laparoscopic pyeloplasty was performed in 29 infants 2 to 11 months old (mean age 6.0 months) weighing 4.1 to 10.9 kg (mean ± SD 7.9 ± 1.6). Followup was available in all except 5 patients (median 13.9 months, IQR 7.7-23.8). Mean operative time was 245 ± 44 minutes. All cases were completed laparoscopically. Three postoperative complications were reported, including ileus, superficial wound infection and pyelonephritis. Two patients had persistent symptomatic and/or radiographic evidence of obstruction, and required reoperative pyeloplasty. The overall success rate was 92%.
CONCLUSIONS: Laparoscopic pyeloplasty in infants remains a technically challenging procedure limited to select centers. Our early experience revealed a success rate comparable to that of other treatment modalities with minimal morbidity.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23123373     DOI: 10.1016/j.juro.2012.10.067

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Evaluation of robotic-assisted laparoscopic and open pyeloplasty in children: single-surgeon experience.

Authors:  P Murthy; J A Cohn; M S Gundeti
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

2.  Single-stage surgical approach in complicated paediatric ureteral duplication: surgical and functional outcome.

Authors:  Verena Ellerkamp; Phillip Szavay; Tobias Luithle; Juergen F Schäfer; Oliver Amon; Joerg Fuchs
Journal:  Pediatr Surg Int       Date:  2013-09-27       Impact factor: 1.827

Review 3.  Minimally invasive surgery in management of renal tumours in children.

Authors:  Kathrine Olaussen Eriksen; Navroop Singh Johal; Imran Mushtaq
Journal:  Transl Pediatr       Date:  2016-10

4.  Laparoscopic and robotic pyeloplasty as minimally invasive alternatives to the open approach for the treatment of uretero-pelvic junction obstruction in infants: a multi-institutional comparison of outcomes and learning curves.

Authors:  C Andolfi; A M Lombardo; J Aizen; X Recabal; J P Walker; N S Barashi; F Reed; P J Lopez; D T Wilcox; M S Gundeti
Journal:  World J Urol       Date:  2022-01-19       Impact factor: 4.226

5.  Is Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction in Infants Under 1 Year of Age a Good Option?

Authors:  Corina Zamfir Snykers; Elea De Plaen; Sophie Vermersch; Manuel Lopez; Karim Khelif; Stephane Luyckx; Paul Philippe; Francois Varlet; Henri Steyaert
Journal:  Front Pediatr       Date:  2019-09-25       Impact factor: 3.418

Review 6.  An up-to-date overview of minimally invasive treatment methods in ureteropelvic junction obstruction.

Authors:  Rahmi Gokhan Ekin; Orcun Celik; Yusuf Ozlem Ilbey
Journal:  Cent European J Urol       Date:  2015-06-18

Review 7.  Managing Ureteropelvic Junction Obstruction in the Young Infant.

Authors:  Niccolo Maria Passoni; Craig Andrew Peters
Journal:  Front Pediatr       Date:  2020-05-27       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.